Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes
Metrics: PDF 848 views | ?
1 Hematology Department, Hospital Universitario 12 Octubre, CNIO, Universidad Complutense, Madrid, Spain
2 Research Institute of Hospital 12 de Octubre (‘i+12’), Madrid, Spain
3 GIDFYS, European University Miguel de Cervantes, Valladolid, Spain
4 IBSAL, Cancer Research Center (USAL-CSIC), Salamanca, Spain
5 Hematology Department, Hospital Universitario La Fe, Valencia, Spain
6 Hematology Department, Hospital Universitario de León, and IBIOMED, Universidad León, León, Spain
7 Genetics Unit, Hospital Universitario La Fe, Valencia, Spain
8 Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain
9 Universidad Europea de Madrid, Madrid, Spain
* These authors have contributed equally to this work
Published: July 20, 2018
This article has been corrected: In the Materials and Methods section, the data access link is incorrect. In addition, reference 37 was also listed incorrectly. The proper information is given below:
Materials and Methods: The data discussed in this publication have been deposited in the NCBI Sequence Read Archive (SRA)  and are accessible through (http://www.ncbi.nlm.nih.gov/sra/SRP102906).
References: 37. Leinonen R, Sugawara H, Shumway M. The sequence read archive. Nucleic Acids Res. 2011; 39 (Database issue): D19-D21.
Original article: Oncotarget. 2017; 8:106948-106961. DOI: https://doi.org/10.18632/oncotarget.22157.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.